Buscar en
Enfermería Clínica
Toda la web
Inicio Enfermería Clínica Clinical determinants of oxygen saturation and length of hospitalisation of COVI...
Información de la revista
Vol. 33. Núm. S1.
The 4th Udayana International Nursing Conference (4th INC)
Páginas S38-S44 (Marzo 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
73
Vol. 33. Núm. S1.
The 4th Udayana International Nursing Conference (4th INC)
Páginas S38-S44 (Marzo 2023)
Acceso a texto completo
Clinical determinants of oxygen saturation and length of hospitalisation of COVID-19 patients: A cross-sectional study in Indonesia
Visitas
73
Evi Susantia, Maria Rista Okstoriab, Siti Wijayantib, Hilda Damayantib, Hasriza Eka Putrac,d, Roselyn Chipojolae, Muhammad Fauzi Rahmanf, Maria Dyah Kurniasarig, Mega Hasanul Hudaa,f,h,
Autor para correspondencia
megahasanulhuda@gmail.com

Corresponding author.
a Universitas Prima Nusantara, Bukittinggi, Indonesia
b Mekarsari Hermina Hospital West Java, Bogor, West Java, Indonesia
c Pekanbaru Hermina Hospital Riau Province, Pekanbaru, Riau, Indonesia
d RSUD Perawang Riau Province, Perawang Barat, Tualang, Siak Regency, Riau, Indonesia
e Kamuzu University of Health Sciences, Blantyre, Malawi
f Research and Development Unit Hermina Hospital Group, Jakarta, Indonesia
g Universitas Kristen Setya Wacana Salatiga, Salatiga, Indonesia
h Badan Riset dan Inovasi Nasional, Jakarta, Indonesia
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Suplemento especial
Este artículo forma parte de:
Vol. 33. Núm S1

The 4th Udayana International Nursing Conference (4th INC)

Más datos
Abstract
Aims

Indonesia was one of the countries with the highest COVID-19 positive cases. Understanding the length of hospitalisation is critical for anticipating bed demand and resource allocation, such as oxygen. This study aims to examine the determinants of oxygen saturation and the length of hospitalisation in Hermina Mekarsari Hospital, West Java, Indonesia.

Methods

This cross-sectional study uses medical records from June to August 2021. The inclusion criteria were: COVID-19 patients aged between18 and 65, fully conscious, and not using mechanical ventilation. Participants who passed away during hospital stay were excluded. We used demographic information, laboratory data, and the clinician's assessments of the patients admitted to the hospital. Linear regression was performed for oxygen saturation on day seven, while logistic regression analysis was conducted to predict the length of hospital stay.

Results

In total, 371 participants with an average age of 47.2 (standard deviation 15.8) years were included. Most participants were female (57.7%) and smoking (78.4%). The results indicated that decreasing oxygen saturation was reported in vomiting patients (β=1.63, p-value=.001), hypertensive patients (β 1.18 with, p-value=.034), and patients with the increased respiratory rate (β=0.28, p-value=.000). In the logistic regression, we found that respondents who experienced dyspnoea, headache, fever, an increasing number of D-Dimer and blood glucose, and those with diabetes mellitus were more likely to stay more than 14 days.

Conclusions

Oxygen saturation was influenced by vomiting, hypertension, and increasing respiratory rate. Length of hospitalisation of more than 14 days was influenced by dyspnoea, headache, fever, increased number of D-Dimer, blood glucose, and diabetes mellitus. Identifying the determinants of oxygen saturation and length of stay can inform health professionals in designing a suitable intervention to reduce mortality and length of stay among COVID-19 patients in Indonesia.

Keywords:
Oxygen saturation
Hospitalisation
Determinant factors
Cross-sectional study
COVID-19
Texto completo
Introduction

The novel coronavirus disease 2019 (COVID-19) was first discovered in Wuhan in December 2019 before spreading worldwide. In Indonesia, the deaths related to COVID-19 reached 143,592 cases from a total of 4,249,323 positive cases.1 In mid-2020, World Health Organization (WHO) reported that the number of cases in Indonesia increased by 50% or more.1 From January to April 2022, the total number of cases was 6,015,748, with 155,164 deaths.1

A previous study pointed out that 57% of deaths due to COVID-19 occurred in men aged between 18 and 59, with a cumulative mortality rate of 13 deaths in every 100,000 people.2 WHO reported that Indonesia's health system was under tremendous strain due to the rising prevalence of COVID-19, including the supply of oxygen (WHO, 2021). Oxygen saturation90% predicts mortality among COVID-19 patients with respiratory distress after oxygenation.2 Therefore, it is crucial to determine the risk variables associated with oxygen saturation in the triage of patients.

Hospitalisation due to COVID-19 profoundly affected global health systems, i.e., overcrowding health facilities, demanding many health experts, causing burnout, and rising health finance and medical costs.3 A previous investigation has revealed that in Ghana, the presence of hypertension and diabetes mellitus influenced the length of stay among COVID-19 patients.4 However, their data is limited to only participants’ characteristics and comorbidities as the predictor. A more thorough understanding of the determinants of the length of hospitalisation is critical for anticipating bed demand and resource allocation, especially in resource-constrained settings. To fill the gaps and support the health care services, this study aims to identify the determinants of oxygen saturation and length of hospitalisation among COVID-19 patients in Indonesia.

Methods

This cross-sectional study uses data from the medical record in Hermina Mekarsari Hospital, West Java, Indonesia. West Java was the province where the first COVID-19 cases were confirmed.5 The data were collected in the second wave of the epidemic, between May and August 2022, when the number of COVID-19 cases increased from an average of 1170 cases per week to 6949 cases per week in West Java. The inclusion criteria were: (a) COVID-19 positive, (b) aged between 19 and 64, (c) fully conscious, and (d) not using mechanical ventilation. We excluded participants who passed away during their treatment at the hospital.

The sample size was calculated based on the previous study, reporting an odds ratio (OR) of 0.2 between comorbidities on length of stay6 to achieve the power of 80% and a significance level of 0.05. We set the final sample size to at least 371 patients. We extracted demographic and health characteristic data, signs and symptoms, comorbidities, clinical assessment, and laboratory indices from medical records when patients were admitted to the hospital. The study protocol was approved by The Ethical Review Board of Saint Carolus Health Science, Indonesia (No. 005/KEPPKSTIKSC/I/2022).

We analysed the data using the Statistical Package for the Social Sciences for Windows (version 26.0; SPSS, Chicago, IL). The descriptive statistics were analysed using percentage, frequency, mean, and standard deviation to report the distribution of the variables. In bivariate analysis, we used a t-test to compare the mean between oxygen saturation and some potential factors, for instance, demographic and vital signs, signs and symptoms at admission, comorbid, and laboratory indices. We used linear regression to examine the factors of oxygen saturation among the COVID-19 patients, while binary logistics was used to analyse the clinical determinants of length of stay.

ResultsCharacteristics of participants

Of the 371 participants recruited, all completed the survey. The characteristics of the participants are described in Table 1. The results indicated that most participants were female, smoking, had several symptoms for instance dry cough, fever, tachipnoea. Additionally, most of the participant also had comorbidity.

Table 1.

Participants’ characteristics.

Variables  Frequency (n=371)  Percentage (%) (n=371) 
Age, Mean (SD)  47.2  15.8 
Gender
Female  214  57.7 
Male  157  42.3 
Smoking
Yes  291  78.4 
No  80  21.6 
Haemoglobin, Mean (SD)  13.1  7.5 
Thrombocyte, Mean (SD)  276,044.4  116,244.4 
D-dimer, Mean (SD)  481.1  557.1 
Blood glucose, Mean (SD)  152.5  116 
Temperature, Mean (SD)  37.5  1.0 
Heart rate, Mean (SD)  94.3  10.7 
RR, Mean (SD)  27.2  3.7 
Systole, Mean (SD)  124.8  15.9 
Dry cough
Yes  328  88.4 
No  43  11.6 
Fever
Yes  328  88.4 
No  43  11.6 
Tachypnoea
Yes  306  82.5 
No  65  17.5 
Chest distress
Yes  60  16.2 
No  311  83.8 
Myalgia
Yes  122  32.9 
No  249  67.1 
Headache
Yes  123  33.2 
No  248  66.8 
Vomitus
Yes  74  19.9 
No  297  80.1 
Diarrhoea
Yes  35  9.4 
No  336  90.6 
Diabetes mellitus
Yes  92  24.8 
No  279  75.2 
Immunodeficiency
Yes  0.3 
No  370  99.7 
Hypertension
Yes  92  24.8 
No  729  75.2 
Pregnancy
Yes  58  15.6 
No  313  84.4 
Comorbidity
Yes  208  56.1 
No  163  43.9 

Note. N: frequency, SD: standard deviation, RR: respiratory rate, %: percentage.

Clinical determinants of oxygen saturation and length of stay

The determinants of oxygen saturation and length of hospitalisation are described in Tables 2 and 3. The results indicated that participant who had vomitus, hypertension, and also tachypnoea were significantly reported decreasing oxygen saturation. From analysis, we also found that patient who had tachypnoea.

Table 2.

Regression analysis of oxygen saturation among COVID-19 patients (n=371).

Variable  M  SD  B  Standardised β  p-Value 
Age
<30 years  303  81.7  −0.001  −0.002  0.968 
≥30 years  68  18.3  Ref  Ref   
Wheezing
Yes  29  7.8  −1.25  −0.09  0.132 
No  342  92.2  Ref  Ref   
Fever
Yes  262  70.6  −0.06  −0.01  0.901 
No  109  29.4  Ref  Ref   
Chest distress
Yes  60  16.2  0.55  0.05  0.383 
No  311  83.8  Ref  Ref   
Vomitus
Yes  74  19.9  −1.63  −0.17  0.001 
No  297  80.1  Ref  Ref   
Diabetes mellitus
Yes  92  24.8  0.22  0.02  0.710 
No  279  75.2  Ref  Ref   
Hypertension
Yes  92  24.8  −1.18  −1.22  0.034 
No  279  75.2  Ref  Ref   
Pregnancy
Yes  58  15.6  0.14  0.01  0.848 
No  312  84.1  Ref  Ref   
Comorbid
Yes  208  56.1  0.08  0.01  0.884 
No  163  43.9  Ref  Ref   
Headache
Yes  123  33.2  0.09  0.01  0.853 
No  248  66.8  Ref  Ref   
Haemoglobin
Abnormal  166  44.7  0.04  0.02  0.641 
Normal  205  55.3  Ref  Ref   
D-dimer
Abnormal  127  41.2  0.00  −0.06  0.264 
Normal  181  58.8  Ref  Ref   
Blood glucose
Abnormal  71  20.2  −0.002  −0.063  0.303 
Normal  281  79.8  Ref  Ref   
Tachypnoea
Abnormal  359  96.8  −0.28  −0.26  0.000 
Normal  12  3.2  Ref  Ref   
HR
Abnormal  76  20.5  −0.03  −0.08  0.118 
Normal  295  79.5  Ref  Ref   

Note: M: mean, SD: standard deviation, B: beta, RR: respiratory rate, HR: heart rate.

Bold: Significant value.

Table 3.

Regression analysis of length of hospitalisation more than 14 days (n=371).

Variable  N  OR (95% CI)  SE  p-Value 
Tachypnoea      3.80 (1.11–13.0)     
Yes  306  82.5  Ref  0.63  0.033 
No  65  17.5       
Headache      1.23 (0.11–0.51)     
Yes  123  33.2  Ref  0.40  0.000 
No  248  66.8       
Fever      2.24 (1.07–4.68)     
Yes  262  70.6  Ref  0.38  0.032 
No  109  29.4       
D-dimer      1.00 (1.00–1.001)     
Abnormal  127  41.2  Ref  0.00  0.006 
Normal  181  58.8       
Blood glucose      1.00 (1.00–1.005)     
Abnormal  71  20.2  Ref  0.01  0.006 
Normal  281  79.8       
HR           
Abnormal  76  20.5  0.58 (0.29–1.13)  0.34  0.110 
Normal  295  79.5  Ref     
Diabetes mellitus      2.23 (1.08–4.61)     
Yes  92  24.8  Ref  0.37  0.030 
No  279  75.2       
Pregnancy           
Yes  58  15.6  0.27 (0.06–1.21)  0.77  0.088 
No  312  84.1  Ref     
Comorbidity           
Yes  208  56.1  0.93 (0.43–1.93)  0.40  0.847 
No  163  43.9  Ref     

Note: N: total number, %: percentage, OR: odd ratio, SE: standard error, HR: heart rate.

Bold: Significant value.

Discussion

In this study, tachypnoea has the strongest relationship with oxygen saturation and length of stay. This is in line with the previous study that revealed the manifestation of tachypnoea due to the distribution of the majority of Angiotensin-converting enzyme 2 (ACE2) receptors in lung epithelial cells, where then the SARS-CoV-2 virus enters and destroys the alveoli.7,8 T helper CD4 cells and T cytotoxic CD8 cells begin to be trapped in the lung tissues. These cells play a role in fighting off the viruses, but they also play a role in the inflammation and subsequent lung injuries.9

It is important to note that vomiting significantly predicted lowered oxygen saturation. This aligns with the previous study with 27 autopsy cases, stating that vomiting followed by inhalation of gastric contents into the bronchial tract may cause pulmonary inflammation.10 The severity of lung injury increases significantly with the large volume of gastric contents aspirated and the low potential hydrogen (PH) of gastric contents.11 Patients experiencing the aspiration of gastric contents may experience respiratory signs and symptoms, such as wheezing, coughing, dyspnoea, cyanosis, pulmonary oedema, and hypoxaemia, which may develop into severe ARDS.12

Our study also found that hypertension contributed to lowered oxygen saturation. This study also aligned with the previous study, revealing that COVID-19 patients who suffered from hypertension as comorbidity showed low oxygen saturation levels.13 The possible explanation for this is the Angiotensin-Converting Enzyme 2 (ACE2) receptor as the site of attachment for the SARS-CoV-2 virus on the cell surface to enter the cell.14,15 The ACE2 catalyses the conversion of angiotensin II (a vasoconstrictor peptide) to angiotensin 1–7 (a vasodilator). This can bring influence the occurrence of hypertension in COVID-19 patients.

In addition, our study has shown that dyspnoea, fever, and diabetes mellitus (DM) are prognostic factors for a more extended hospitalisation. This result is consistent with the previous study, claiming that patients with more severe symptoms tend to be hospitalised longer than patients with less severe symptoms of the same diagnosis.16 In COVID-19 cases, dyspnoea and fever are signs of pneumonia, which could be classified as moderate symptoms of COVID-19.17 Meanwhile, studies on immunity showed that poorly controlled diabetes could inhibit the lymphocyte response and impair the function of monocytes, macrophages, and neutrophils,18,19 which means a longer hospitalisation.

Finally, this study shows that high D-Dimer also influences the length of hospitalisation. An increase in D-Dimer is a sign of coagulopathy, indicating that severe sepsis has occurred, leading to a critical illness.20 This suggests that the D-Dimer level is related to the disease severity, which has also been proven in a previous study describing that the D-Dimer level at admission is a risk factor for severe symptoms and death.6

This study had some limitations. First, our study recruits participants from one hospital, so the generalisation is low. Future study needs to include multiple centres and locations. Second, the causal relationship was difficult to build since we used a cross-sectional design. Longitudinal studies are required to explore the changes in oxygen saturation among COVID-19 patients. This study indicates important variables associated with oxygen saturation, including tachypnoea, vomiting, and hypertension. Health professionals should consider some variables, including dyspnoea, headache, fever, D-dimer, blood glucose, and diabetes mellitus, in reducing the length of hospitalisation of COVID-19 patients.

Funding

This research received no funding.

Conflict of interest

The authors declare no conflict of interest.

Acknowledgment

We thank Douglas S Umboh, MD, Director of Hermina Mekarsari Hospital, for the permission in conducting this research.

References
[1]
World Health Organization.
Update on coronavirus disease in Indonesia.
(2020),
[2]
C. Wu, X. Chen, Y. Cai, X. Zhou, S. Xu, H. Huang, et al.
Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.
JAMA Intern Med, 180 (2020), pp. 934-943
[3]
A.E. Brown, E. Heinsbroek, M.M. Kall, H. Allen, K. Beebeejaun, P. Blomquist, et al.
Epidemiology of confirmed COVID-19 deaths in adults, England, March–December 2020.
Emerg Infect Dis, 27 (2021), pp. 1468
[4]
M.-R. Sohrabi, R. Amin, A. Maher, A. Bahadorimonfared, S. Janbazi, K. Hannani, et al.
Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran.
BMC Infect Dis, 21 (2021), pp. 1-13
[5]
N. Rees, L. Smythe, C. Hogan, J. Williams.
Paramedic experiences of providing care in Wales (UK) during the 2020 COVID-19 pandemic (PECC-19): a qualitative study using evolved grounded theory.
BMJ Open, 11 (2021), pp. e048677
[6]
M.E. Ashinyo, V. Duti, S.D. Dubik, K.E. Amegah, S. Kutsoati, E. Oduro-Mensah, et al.
Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study.
[7]
D.N. Aisyah, C.A. Mayadewi, H. Diva, Z. Kozlakidis, W. Adisasmito.
A spatial–temporal description of the SARS-CoV-2 infections in Indonesia during the first six months of outbreak.
PLOS ONE, 15 (2020), pp. e0243703
[8]
H. Alwafi, A.Y. Naser, S. Qanash, A.S. Brinji, M.A. Ghazawi, B. Alotaibi, et al.
Predictors of length of hospital stay, mortality, and outcomes among hospitalised COVID-19 patients in Saudi Arabia: a cross-sectional study.
J Multidiscipl Healthc, 14 (2021), pp. 839
[9]
K. Yuki, M. Fujiogi, S. Koutsogiannaki.
COVID-19 pathophysiology: a review.
Clin Immunol, 215 (2020), pp. 108427
[10]
A. Parasher.
COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment.
Postgrad Med J, 97 (2021), pp. 312-320
[11]
World Health Organization.
Living guidance for clinical management of COVID-19.
(2022),
[12]
Y. Sakai, M. Ohira, Y. Yokokawa.
Cough strength is an indicator of aspiration risk when restarting food intake in elderly subjects with community-acquired pneumonia.
Respir Care, 65 (2020), pp. 169-176
[13]
L.C. Myers, S.M. Parodi, G.J. Escobar, V.X. Liu.
Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California.
JAMA, 323 (2020), pp. 2195-2198
[14]
E.B. Hunt, A. Sullivan, J. Galvin, J. MacSharry, D.M. Murphy.
Gastric aspiration and its role in airway inflammation.
Open Respir Med J, 12 (2018), pp. 1
[15]
P. Kosutova, P. Mikolka.
Aspiration syndromes and associated lung injury: incidence, pathophysiology and management.
Physiol Res, 70 (2021), pp. S567
[16]
J.R. Delanghe, M.M. Speeckaert, M.L. De Buyzere.
The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections.
Clin Chim Acta, 505 (2020), pp. 192
[17]
S. Shibata, H. Arima, K. Asayama, S. Hoshide, A. Ichihara, T. Ishimitsu, et al.
Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19.
Hypertens Res, 43 (2020), pp. 1028-1046
[18]
S. Crankson, S. Pokhrel, N.K. Anokye.
Determinants of COVID-19-related length of hospital stays and long COVID in Ghana: a cross-sectional analysis.
Int J Environ Res Public Health, 19 (2022), pp. 527
[19]
World Health Organization.
COVID-19 clinical management: living guidance.
(2021),
[20]
A. Rawshani, E.A. Kjölhede, A. Rawshani, N. Sattar, K. Eeg-Olofsson, M. Adiels, et al.
Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: a nationwide retrospective cohort study.
Lancet Regional Health-Europe, 4 (2021), pp. 100105

Peer-review under the responsibility of the scientific committee of “The 4th Udayana International Nursing Conference (4th INC)”. Full text and its content are under the responsibility of the authors of the article.

Copyright © 2023. Elsevier España, S.L.U.. All rights reserved
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.enfcli.2023.11.005
No mostrar más